- Home
- CIO vs OCGN Comparison
CIO vs OCGN Comparison
Compare CIO & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIO
- OCGN
- Stock Information
- Founded
- CIO 2013
- OCGN 2013
- Country
- CIO Canada
- OCGN United States
- Employees
- CIO N/A
- OCGN N/A
- Industry
- CIO Real Estate Investment Trusts
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIO Real Estate
- OCGN Health Care
- Exchange
- CIO Nasdaq
- OCGN Nasdaq
- Market Cap
- CIO 280.5M
- OCGN 321.7M
- IPO Year
- CIO 2014
- OCGN N/A
- Fundamental
- Price
- CIO $7.01
- OCGN $1.77
- Analyst Decision
- CIO Hold
- OCGN Strong Buy
- Analyst Count
- CIO 1
- OCGN 3
- Target Price
- CIO N/A
- OCGN $6.00
- AVG Volume (30 Days)
- CIO 548.8K
- OCGN 7.1M
- Earning Date
- CIO 10-30-2025
- OCGN 11-07-2025
- Dividend Yield
- CIO 5.72%
- OCGN N/A
- EPS Growth
- CIO N/A
- OCGN N/A
- EPS
- CIO N/A
- OCGN N/A
- Revenue
- CIO $168,892,000.00
- OCGN $4,754,000.00
- Revenue This Year
- CIO $0.60
- OCGN N/A
- Revenue Next Year
- CIO $3.53
- OCGN N/A
- P/E Ratio
- CIO N/A
- OCGN N/A
- Revenue Growth
- CIO N/A
- OCGN N/A
- 52 Week Low
- CIO $4.19
- OCGN $0.52
- 52 Week High
- CIO $7.01
- OCGN $1.90
- Technical
- Relative Strength Index (RSI)
- CIO 74.58
- OCGN 75.36
- Support Level
- CIO $6.93
- OCGN $1.31
- Resistance Level
- CIO $6.97
- OCGN $1.78
- Average True Range (ATR)
- CIO 0.02
- OCGN 0.16
- MACD
- CIO -0.01
- OCGN 0.03
- Stochastic Oscillator
- CIO 93.75
- OCGN 82.67
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").